• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.13% Nasdaq Up0.70%

    Pacira Pharmaceuticals, Inc. (PCRX)

    -NasdaqGS
    93.51 Up 1.42(1.54%) Dec 26, 4:00PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue 52,048   47,166   36,662   33,565  
    Cost of Revenue20,391  19,954  18,127  18,376  
    Gross Profit 31,657   27,212   18,535   15,189  
    Operating Expenses
    Research Development4,424  5,216  5,204  4,836  
    Selling General and Administrative28,217  24,837  22,589  20,172  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (984) (2,841) (9,258) (9,819)
    Income from Continuing Operations
    Total Other Income/Expenses Net17  (118)(112)(209)
    Earnings Before Interest And Taxes(967)(2,959)(9,370)(10,028)
    Interest Expense2,037  2,078  2,107  1,928  
    Income Before Tax(3,004)(5,037)(11,477)(11,956)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(3,004)(5,037)(11,477)(11,956)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (3,004) (5,037) (11,477) (11,956)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (3,004) (5,037) (11,477) (11,956)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.